drug Archives

Dangerfield Rejoins Gallagher & Kennedy

Dangerfield - color
by in Business News | Legal

Gallagher & Kennedy, P.A., a full service business law firm, announced that Mark C. Dangerfield has rejoined the firm as shareholder in the Litigation Department. Mr. Dangerfield practices in the areas of commercial and appellate litigation, including business torts and contracts, professional malpractice, securities and real estate. Dangerfield left Gallagher & Kennedy in 2010 to… Read More →

Dangerfield Rejoins Gallagher & Kennedy

Dangerfield - color
by in Business News | Legal

Gallagher & Kennedy, P.A., a full service business law firm, announced that Mark C. Dangerfield has rejoined the firm as shareholder in the Litigation Department. Mr. Dangerfield practices in the areas of commercial and appellate litigation, including business torts and contracts, professional malpractice, securities and real estate. Dangerfield left Gallagher & Kennedy in 2010 to… Read More →

FDA approves return of nausea treatment

morning
by in Business News | Healthcare

The only drug specifically designed for the treatment of morning sickness in pregnant women will be back on the market in June of this year. The treatment was pulled from shelves thirty years ago but a thorough investigation finds the drug safe and the FDA gave its approval yesterday. “This is fabulous news,” says Dr.… Read More →

FDA approved thyroid cancer drug tested by TGen

medical.research
by in Bioscience | Featured | Healthcare

The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). The U.S. Food and Drug Administration approved cabozantinib for the treatment of progressive, metastatic medullary thyroid cancer (MTC), a rare endocrine gland cancer affecting the… Read More →